N46.021 Azoospermia due to drug therapy

Name of the Condition

• Azoospermia due to drug therapy

Summary

Azoospermia due to drug therapy is a condition characterized by the complete absence of sperm in a man's ejaculate, resulting from the effects of medication. This form of male infertility occurs when drug therapy disrupts sperm production or delivery, leading to impaired fertility.

Causes

Azoospermia due to drug therapy is caused by medications that interfere with spermatogenesis or reproductive function. Drugs such as chemotherapy agents, anabolic steroids, certain antibiotics, or hormonal therapies may suppress sperm production or cause temporary or permanent damage to testicular function.

Risk Factors

• Use of medications known to affect sperm production (e.g., chemotherapy, anabolic steroids)
• Prolonged or high-dose drug therapy
• Pre-existing testicular or hormonal conditions that may exacerbate drug effects

Symptoms

• Inability to conceive a child after 12 months of unprotected intercourse
• No visible symptoms may be present beyond infertility, though underlying drug therapy may cause related side effects

Diagnosis

Diagnosis involves a semen analysis to confirm the absence of sperm. Additional tests may include hormonal profiling to assess testosterone and follicle-stimulating hormone levels, and a review of medication history to identify potential drug-related causes. Imaging studies or genetic testing may be performed if other underlying conditions are suspected.

Treatment Options

Treatment focuses on addressing the underlying drug therapy, where possible, by adjusting or discontinuing the causative medication. Assisted reproductive technologies (ART) such as in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) may be considered if sperm production does not recover. Hormone therapy or surgical interventions are not typically effective for drug-induced azoospermia unless the drug effect is reversible.

Prognosis and Follow-Up

Prognosis depends on the reversibility of the drug effect. Some medications may cause temporary azoospermia, with sperm production returning after discontinuation. Others, particularly chemotherapy, may lead to permanent infertility. Follow-up semen analyses are recommended to monitor recovery, and counseling on fertility preservation options (e.g., sperm banking) should be offered before initiating high-risk drug therapy.

Complications

• Permanent infertility if sperm production does not recover
• Emotional or psychological distress related to infertility
• Potential need for long-term assisted reproductive technologies

Lifestyle & Prevention

• Discuss fertility risks with healthcare providers before starting high-risk medications
• Consider sperm banking as a preventive measure for patients undergoing chemotherapy or other gonadotoxic therapies
• Avoid unnecessary use of medications known to impair sperm production

When to Seek Professional Help

Seek medical evaluation if infertility is suspected, especially in patients undergoing drug therapy known to affect reproductive function. Early consultation with a urologist or reproductive specialist is recommended to assess sperm production and explore fertility preservation options.

Tips for Medical Coders

Document the specific drug therapy associated with the azoospermia, as this is critical for accurate coding. Ensure the medical record clearly links the medication to the absence of sperm, including details on timing, dosage, and duration of therapy. Verify that the diagnosis aligns with the clinical presentation and that no other causes of azoospermia are documented.